Andreas Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.52 M
- Revenue Growth 674.06%
- Profit Growth 1204.06%
- Ebitda 1188.09%
- Net Worth 3269.16%
- Total Assets -28.21%
About Andreas Pharma
Andreas Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 September 2017 (Seven years and four months 11 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹6.52 M.
Ujjwal Jha, Saurabh Singh, Indraraj Neogi, and Two other members serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U36999MH2017PTC300287
-
Company No.
300287
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Sep 2017
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Andreas Pharma?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ujjwal Jha
|
Director | 15-Feb-2022 | Current |
|
Indraraj Neogi
|
Director | 15-Feb-2022 | Current |
|
Saurabh Singh
|
Director | 27-Dec-2019 | Current |
|
Vinay Singh
|
Director | 27-Dec-2019 | Current |
|
Ashish Singh
|
Director | 29-Sep-2017 | Current |
Financial Performance of Andreas Pharma.
Andreas Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 674.06% increase. The company also saw a substantial improvement in profitability, with a 1204.06% increase in profit. The company's net worth Soared by an impressive increase of 3269.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Andreas Pharma?
In 2023, Andreas Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Rjms Agro Private LimitedSaurabh Singh, Indraraj Neogi and 2 more are mutual person
-
Rjms Paper Private Limited
Saurabh Singh, Indraraj Neogi and 2 more are mutual person
-
Prohealthcare Lifescience Private Limited
Saurabh Singh and Ashish Singh are mutual person
-
Rjms Lab Private Limited
Saurabh Singh, Indraraj Neogi and 2 more are mutual person
-
Chatushkon Design Llp
Indraraj Neogi is a mutual person
-
Daundi Biological Private Limited
Vinay Singh and Ashish Singh are mutual person
Charges (Loans)
₹6.52 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.60 Cr
- Others : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Oct 2023 | Others | ₹0.52 M | Open |
| 26 Jul 2023 | Hdfc Bank Limited | ₹6.00 M | Open |
How Many Employees Work at Andreas Pharma?
Unlock and access historical data on people associated with Andreas Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Andreas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Andreas Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
